Phase I/II trial of nab-Paclitaxel,Carboplatin,plus Bevacizumab chemotherapy for patients with advanced Non-Squamous Non-Small Cell Lung Cancer.
Phase 1
- Conditions
- Advanced Non-Squamous Non-Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000013201
- Lead Sponsor
- Cancer Institute Hospital of JFCR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 61
Inclusion Criteria
Not provided
Exclusion Criteria
The patients who have brain metastasis and have symptom or need therapy. The patients who have hemoptysis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PhaseI:Dose Limiting Toxicity(DLT),Minimal Tolerated Dose(MTD),Recommended Dose(RD) PhaseII:Objective Response Rate(ORR)
- Secondary Outcome Measures
Name Time Method PhaseI:Safety,Objective Response Rate(ORR),Progression Free Survival(PFS),Overall Survival(OS)